Novo Nordisk H1 2023 Investor Presentation AHA November

Novo Nordisk investor presentation covering first half 2023 results, delivered at the AHA conference in Philadelphia on November 11, 2023. The presentation includes discussion of the SELECT trial, covering efficacy and safety data, as well as next steps in the company's focused healthcare strategy.